The indications for albumin use with the largest number of patients over the 6-month study period were sepsis or septic shock (25.3%), hypotension or hypovolemia (19.4%), intra-dialytic hypotension (13.4%), fluid support in surgery (10.8%), and nephrosis or nephropathy (10.8%) (Table 2). This evidence concerns the gene ALB and nephrosis.